sipatrigine has been researched along with Reperfusion Injury in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Graham, SH; Kawaguchi, K | 1 |
| Henshall, DC; Kawaguchi, K; Simon, RP | 1 |
2 other study(ies) available for sipatrigine and Reperfusion Injury
| Article | Year |
|---|---|
Neuroprotective effects of the glutamate release inhibitor 619C89 in temporary middle cerebral artery occlusion.
Topics: Animals; Blood Gas Analysis; Cerebral Arteries; Cerebral Infarction; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Ischemic Attack, Transient; Male; Neostriatum; Neuroprotective Agents; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury | 1997 |
Parallel dose-response studies of the voltage-dependent Na+ channel antagonist BW619C89, and the voltage-dependent Ca2+ channel antagonist nimodipine, in rat transient focal cerebral ischaemia.
Topics: Animals; Blood Glucose; Blood Pressure; Body Temperature; Brain; Calcium Channel Blockers; Dose-Response Relationship, Drug; Electric Stimulation; Hydrogen-Ion Concentration; Ischemic Attack, Transient; Male; Neuroprotective Agents; Nimodipine; Piperazines; Pyrimidines; Rats; Rats, Sprague-Dawley; Reperfusion Injury; Sodium Channel Blockers | 1999 |